AbbVie wins U.S. antitrust approval to buy Allergan
May 05, 2020 at 18:13 PM EDT
Drugmaker AbbVie has won U.S. antitrust approval to buy Botox-maker Allergan, a blockbuster $63 billion deal when it was announced last year, the companies announced on Tuesday.
